La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine < 1-Methyl-4-phenylpyridinium  Facettes :

List of bibliographic references indexed by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Number of relevant bibliographic references: 82.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000243 (2016) Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada]Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
000273 (2016) Mohammed Filali [Canada] ; Robert Lalonde [France]Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
000424 (2016) Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
000522 (2015) Tom M. Johnston [Canada] ; Susan H. FoxSymptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates.
000610 (2015) Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud]Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
000678 (2015) Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni]Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000801 (2015) Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di PaoloChanges in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
000947 (2014) Mohammad Parsanejad ; Yi Zhang ; Dianbo Qu ; Isabella Irrcher [Canada] ; Maxime W C. Rousseaux ; Hossein Aleyasin ; Fatemeh Kamkar ; Steve Callaghan ; Ruth S. Slack ; Tak W. Mak ; Stephen Lee ; Daniel Figeys [Canada] ; David S. Park [Canada]Regulation of the VHL/HIF-1 pathway by DJ-1.
000995 (2014) Marianna Sikorska [Canada] ; Patricia Lanthier [Canada] ; Harvey Miller [Canada] ; Melissa Beyers [Canada] ; Caroline Sodja [Canada] ; Bogdan Zurakowski [Canada] ; Sandhya Gangaraju [Canada] ; Siyaram Pandey [Canada] ; Jagdeep K. Sandhu [Canada]Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson’s disease
000A34 (2014) Kelly M. Lohr ; Alison I. Bernstein ; Kristen A. Stout ; Amy R. Dunn ; Carlos R. Lazo ; Shawn P. Alter ; Minzheng Wang ; Yingjie Li ; Xueliang Fan ; Ellen J. Hess ; Hong Yi ; Laura M. Vecchio [Canada] ; David S. Goldstein ; Thomas S. Guillot ; Ali Salahpour [Canada] ; Gary W. MillerIncreased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
000B04 (2014) Jean-Francois Poulin ; Jian Zou ; Janelle Drouin-Ouellet [Royaume-Uni] ; Kwang-Youn A. Kim ; Francesca Cicchetti ; Rajeshwar B. AwatramaniDefining midbrain dopaminergic neuron diversity by single-cell gene profiling
000C37 (2013) Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. SadikotThe transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
000C97 (2013) Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. ParkPerturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)*
000D83 (2013) Maria Gabriela Sánchez [Canada] ; Marc Morissette ; Thérèse Di PaoloEstradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
000E37 (2013) Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di PaoloBasal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
001130 (2012) Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di PaoloSignaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
001133 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas StefanisSelective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
001191 (2012) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. BrotchieL-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001209 (2012) M. Emdadul Haque ; Matthew P. Mount ; Farzaneh Safarpour ; Elizabeth Abdel-Messih ; Steve Callaghan ; Chantal Mazerolle ; Tohru Kitada ; Ruth S. Slack ; Valerie Wallace ; Jie Shen ; Hymie Anisman ; David S. ParkInactivation of Pink1 Gene in Vivo Sensitizes Dopamine-producing Neurons to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Can Be Rescued by Autosomal Recessive Parkinson Disease Genes, Parkin or DJ-1
001646 (2011) Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. ParkInvolvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss*
001A02 (2010) Hamid Y. Qureshi [Canada] ; Hemant K. Paudel [Canada]Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro*

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022